Bivalent Booster "Success" in Hong Kong

The gathering perfect storm...

Following my post “We Knew This Was Coming: "September Bivalent Jabs Much More Harmful" - Study”, here’s the situation in Hong Kong, as an illustration and a train wrack is slow motion.

It’s already the third booster in HK: “Covid-19: Fifth jab to be available in Hong Kong from next Fri” (HKFP, 2022.12.08):

Bookings for the fifth Covid-19 shot – for which people can choose between Sinovac, BioNTech and the Omicron-specific BioNTech – will open online next Friday. Those who are aged 18 or above and who received their fourth jab at least six months ago will be eligible. People who are immunocompromised will be subject to a shortened time interval of three months since their fourth shot. Meanwhile, almost 83 per cent of the population have been triple-jabbed against the coronavirus.

The results didn’t make us to wait for themselves:

The jab-induced SARV-CoV-2 “tolerance” (“Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination”, Science Immunology, 2022.12.22), combined with the new-and-improved mRNA-programmed immunogen (“Bivalent mRNA Vaccines High Rate of Adverse Events: Observational Study at University Hospital Wuerzburg in Germany”, TrialSite News, 2022.12.30) are setting up a stage for something unprecedented, it seems…

The only saving grace may be that not everyone boosting will get 5 doses of mRNA, as more traditional Chinese jabs were also “on the menu” in HK.